Patents by Inventor Catherine Badens

Catherine Badens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220341912
    Abstract: The invention is related to a method for measuring the variability of the red blood cells deformability of an individual by determining the amount of red blood cells having a tank-treading motion in a population of red blood cells from a tested blood sample of said individual, and comparing the amount to a reference amount. The determination of the amount of red blood cells having a tank-treading motion is carried out using a visualisation means such as a brightfield microscope.
    Type: Application
    Filed: April 26, 2022
    Publication date: October 27, 2022
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), ASSISTANCE PUBLIQUE - HOPITAUX DE MARSEILLE, AIX-MARSEILLE UNIVERSITE
    Inventors: Annie VIALLAT, Emmanuele HELFER, Catherine BADENS, Scott ATWELL, Anne CHARRIER
  • Publication number: 20210270816
    Abstract: The invention is related to a method for measuring the variability of the red blood cells deformability of an individual by determining the amount of red blood cells having a tank-treading motion in a population of red blood cells from a tested blood sample of said individual, and comparing the amount to a reference amount. The determination of the amount of red blood cells having a tank-treading motion is carried out using a visualisation means such as a brightfield microscope.
    Type: Application
    Filed: July 10, 2019
    Publication date: September 2, 2021
    Inventors: Annie VIALLAT, Emmanuele HELFER, Catherine BADENS, Scott ATWELL, Anne CHARRIER
  • Publication number: 20180136227
    Abstract: The invention relates to an in vitro method of diagnosis of hereditary xerocytosis in a subject, comprising genotyping the KCNN4 gene encoding the Gardos channel in said subject. The invention also relates to an inhibitor of the KCNN4 protein for use in the treatment of hereditary xerocytosis, in particular in a human subject who is a carrier of the missense mutation c.1055G>A or c.844G>A in the KCNN4 gene.
    Type: Application
    Filed: June 15, 2016
    Publication date: May 17, 2018
    Inventors: Catherine Badens, Isabelle Thuret, Hélène Guizouarn